Rosenzweig EB - Search Results

1

Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience.

Issapour A, Frank B, Crook S, Hite MD, Dorn ML, Rosenzweig EB, Ivy DD, Krishnan US. Issapour A, et al. Among authors: rosenzweig eb. Pediatr Pulmonol. 2022 Mar;57(3):724-733. doi: 10.1002/ppul.25796. Epub 2022 Jan 3. Pediatr Pulmonol. 2022. PMID: 34921523 Free PMC article.

2

Emerging treatments for pulmonary arterial hypertension.

Rosenzweig EB. Rosenzweig EB. Expert Opin Emerg Drugs. 2006 Nov;11(4):609-19. doi: 10.1517/14728214.11.4.609. Expert Opin Emerg Drugs. 2006. PMID: 17064221 Review.

3

Plasma serotonin levels are normal in pulmonary arterial hypertension.

Lederer DJ, Horn EM, Rosenzweig EB, Karmally W, Jahnes M, Barst RJ, Kawut SM. Lederer DJ, et al. Among authors: rosenzweig eb. Pulm Pharmacol Ther. 2008;21(1):112-4. doi: 10.1016/j.pupt.2007.01.003. Epub 2007 Feb 12. Pulm Pharmacol Ther. 2008. PMID: 17374499 Free PMC article.

4

Pulmonary arterial hypertension in children: a medical update.

Rosenzweig EB, Barst RJ. Rosenzweig EB, et al. Indian J Pediatr. 2009 Jan;76(1):77-81. doi: 10.1007/s12098-009-0032-2. Epub 2009 Apr 18. Indian J Pediatr. 2009. PMID: 19391006 Review.

5

Tadalafil for the treatment of pulmonary arterial hypertension.

Rosenzweig EB. Rosenzweig EB. Expert Opin Pharmacother. 2010 Jan;11(1):127-32. doi: 10.1517/14656560903413542. Expert Opin Pharmacother. 2010. PMID: 20001434 Review.

6

Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.

Melnick L, Barst RJ, Rowan CA, Kerstein D, Rosenzweig EB. Melnick L, et al. Among authors: rosenzweig eb. Am J Cardiol. 2010 May 15;105(10):1485-9. doi: 10.1016/j.amjcard.2009.12.075. Epub 2010 Apr 8. Am J Cardiol. 2010. PMID: 20451700

7

Common atrium and pulmonary vascular disease.

Ferdman DJ, Brady D, Rosenzweig EB. Ferdman DJ, et al. Among authors: rosenzweig eb. Pediatr Cardiol. 2011 Jun;32(5):595-8. doi: 10.1007/s00246-011-9919-6. Epub 2011 Feb 23. Pediatr Cardiol. 2011. PMID: 21344289

8

Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension.

Takatsuki S, Rosenzweig EB, Zuckerman W, Brady D, Calderbank M, Ivy DD. Takatsuki S, et al. Among authors: rosenzweig eb. Pediatr Pulmonol. 2013 Jan;48(1):27-34. doi: 10.1002/ppul.22555. Epub 2012 Apr 17. Pediatr Pulmonol. 2013. PMID: 22511577 Free PMC article.

9

Pediatric pulmonary arterial hypertension and hyperthyroidism: a potentially fatal combination.

Trapp CM, Elder RW, Gerken AT, Sopher AB, Lerner S, Aranoff GS, Rosenzweig EB. Trapp CM, et al. Among authors: rosenzweig eb. J Clin Endocrinol Metab. 2012 Jul;97(7):2217-22. doi: 10.1210/jc.2012-1109. Epub 2012 May 23. J Clin Endocrinol Metab. 2012. PMID: 22622024 Free PMC article.

10

Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children.

Krishnan U, Takatsuki S, Ivy DD, Kerstein J, Calderbank M, Coleman E, Rosenzweig EB. Krishnan U, et al. Among authors: rosenzweig eb. Am J Cardiol. 2012 Dec 1;110(11):1704-9. doi: 10.1016/j.amjcard.2012.07.037. Epub 2012 Aug 21. Am J Cardiol. 2012. PMID: 22917554 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters